[
  {
    "ts": null,
    "headline": "Franklin Global Equity Fund Q1 2025 Commentary",
    "summary": "Stock selection was mixed at the region and sector level and modestly detracted overall. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=add304a3ab757e79b9ad0319825662e9fcf86ab08aa9fe55c09c3b0c156d77d8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746057000,
      "headline": "Franklin Global Equity Fund Q1 2025 Commentary",
      "id": 134165585,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2151312477/image_2151312477.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Stock selection was mixed at the region and sector level and modestly detracted overall. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=add304a3ab757e79b9ad0319825662e9fcf86ab08aa9fe55c09c3b0c156d77d8"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Growth Fund Q1 2025 Commentary",
    "summary": "ClearBridge Growth Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=56c76447ce5b6ed0706c2165274a81d9d82a538391b62848956b24d7c420fe39",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746048900,
      "headline": "ClearBridge Growth Fund Q1 2025 Commentary",
      "id": 134165019,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=56c76447ce5b6ed0706c2165274a81d9d82a538391b62848956b24d7c420fe39"
    }
  },
  {
    "ts": null,
    "headline": "High Growth Tech Stocks In The US Market April 2025",
    "summary": "The United States market has experienced a notable upswing, climbing 5.2% in the last week and showing a 9.9% increase over the past year, with earnings projected to grow by 14% annually in the coming years. In this dynamic environment, identifying high growth tech stocks involves focusing on companies that demonstrate robust innovation and adaptability to capitalize on these favorable market conditions.",
    "url": "https://finnhub.io/api/news?id=4599674db491c62259e0a0504957e93c536ed9087a253444737f420347284482",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746013077,
      "headline": "High Growth Tech Stocks In The US Market April 2025",
      "id": 134165936,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The United States market has experienced a notable upswing, climbing 5.2% in the last week and showing a 9.9% increase over the past year, with earnings projected to grow by 14% annually in the coming years. In this dynamic environment, identifying high growth tech stocks involves focusing on companies that demonstrate robust innovation and adaptability to capitalize on these favorable market conditions.",
      "url": "https://finnhub.io/api/news?id=4599674db491c62259e0a0504957e93c536ed9087a253444737f420347284482"
    }
  },
  {
    "ts": null,
    "headline": "FDA approves AbbVie’s upadacitinib for giant cell arteritis",
    "summary": "The approval of the therapy is backed by the outcomes from the randomised Phase III SELECT-GCA trial.",
    "url": "https://finnhub.io/api/news?id=0a9b589e17837d6bd85f6a5658d5cb4aaa81fc10cd143510332f064dc068dcfa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746012075,
      "headline": "FDA approves AbbVie’s upadacitinib for giant cell arteritis",
      "id": 134141613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The approval of the therapy is backed by the outcomes from the randomised Phase III SELECT-GCA trial.",
      "url": "https://finnhub.io/api/news?id=0a9b589e17837d6bd85f6a5658d5cb4aaa81fc10cd143510332f064dc068dcfa"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA) Reports Earnings Tomorrow: What To Expect",
    "summary": "Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market hours. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=4dacee6f799247be4fba63de02976579a53c54d29fdb8c2c048aa15c3b121268",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745997399,
      "headline": "Moderna (MRNA) Reports Earnings Tomorrow: What To Expect",
      "id": 134141614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market hours. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=4dacee6f799247be4fba63de02976579a53c54d29fdb8c2c048aa15c3b121268"
    }
  },
  {
    "ts": null,
    "headline": "Amgen (AMGN) Reports Earnings Tomorrow: What To Expect",
    "summary": "Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect.",
    "url": "https://finnhub.io/api/news?id=99713700d86990d2f4628fa77d30b3262b32a02972e9f6ace0905afd7f853c77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745997274,
      "headline": "Amgen (AMGN) Reports Earnings Tomorrow: What To Expect",
      "id": 134141615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect.",
      "url": "https://finnhub.io/api/news?id=99713700d86990d2f4628fa77d30b3262b32a02972e9f6ace0905afd7f853c77"
    }
  },
  {
    "ts": null,
    "headline": "Biogen Earnings: What To Look For From BIIB",
    "summary": "Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow before the bell. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=5f9be45e02582d49977c427f67ae9a3948f5d601fc8a1a3cbba14ccc10e97425",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745997269,
      "headline": "Biogen Earnings: What To Look For From BIIB",
      "id": 134141616,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow before the bell. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=5f9be45e02582d49977c427f67ae9a3948f5d601fc8a1a3cbba14ccc10e97425"
    }
  },
  {
    "ts": null,
    "headline": "What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings",
    "summary": "Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting earnings tomorrow after the bell. Here’s what to look for.",
    "url": "https://finnhub.io/api/news?id=6879c64aae99681d83a921e7f7cddb135302d0e7eecbbbff224d4188c547f478",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745996697,
      "headline": "What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings",
      "id": 134141617,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting earnings tomorrow after the bell. Here’s what to look for.",
      "url": "https://finnhub.io/api/news?id=6879c64aae99681d83a921e7f7cddb135302d0e7eecbbbff224d4188c547f478"
    }
  }
]